FURTHER STUDIES ON RECURRENCES IN PNEUMOCOCCIC PNEUMONIA WITH SPECIAL REFERENCE TO THE EFFECT OF SPECIFIC TREATMENT
Authors: Elias Strauss, Maxwell Finland
Journal: Annals of Internal Medicine (1942)

Article1 January 1942FURTHER STUDIES ON RECURRENCES IN PNEUMOCOCCIC PNEUMONIA WITH SPECIAL REFERENCE TO THE EFFECT OF SPECIFIC TREATMENTELIAS STRAUSS, M.D., MAXWELL FINLAND, M.D., F.A.C.P.ELIAS STRAUSS, M.D., MAXWELL FINLAND, M.D., F.A.C.P.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-16-1-17 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptIn a previous paper Finland and Winkler1presented an analysis of 57 cases with recurrent attacks of pneumococcic pneumonia. Most of these cases occurred before the present classification of pneumococci2came into use. In a large proportion of the cases, the pneumococci were, therefore, classified as Group IV. Since that time, a much larger group of cases has been accumulated. Pneumococcus typing has improved in efficiency as a result of the introduction of the Neufeld method3and of the more complete classification of the types. Much new information also has been gained about the "higher" types of pneumococci, especially with...References1. FINLANDWINKLER MAW: Recurrences in pneumococcus pneumonia, Am. Jr. Med. Sci., 1934, clxxxviii, 309. CrossrefGoogle Scholar2. COOPERROSENSTEINWALTERPEIZER GCAL: The further separation of types among the pneumococci hitherto included in group IV and the development of therapeutic antisera for these types, Jr. Exper. Med., 1932, lv, 531. CrossrefGoogle Scholar3. SABIN AB: Immediate pneumococcus typing from sputum by the Neufeld reaction, Jr. Am. Med. Assoc., 1933, c, 1584. CrossrefGoogle Scholar4. CECILBALDWINLARSEN RLHSNP: Lobar pneumonia. A clinical and bacteriological study of two thousand typed cases, Arch. Int. Med., 1927, xl, 253. CrossrefGoogle Scholar5. STILLMAN EG: A contribution to the epidemiology of lobar pneumonia, Jr. Exper. Med., 1916, xxiv, 651. CrossrefGoogle Scholar6. CRUICKSHANK R: Pneumococcal infections. II. Lobar pneumonia in the community, Lancet, 1933, i, 621. CrossrefGoogle Scholar7. FINLAND M: The significance of specific pneumococcus types in disease, including types IV to XXXII (Cooper), ANN. INT. MED., 1937, x, 1531. Google Scholar8. FINLANDBROWNBARNES MJWMW: Immune reactions of carriers and non-carriers of type-specific pneumococci, Am. Jr. Hyg., 1940, xxxii, 24. Google Scholar9. FINLANDSUTLIFF MWD: Infections with pneumococcus type III and type VIII, Arch. Int. Med., 1934, liii, 481. CrossrefGoogle Scholar10. SOLOMON S: Chronic Friedländer infections of the lungs, Jr. Am. Med. Assoc., 1940, cxv, 1527. CrossrefGoogle Scholar11. TILGHMANFINLAND RCM: Clinical significance of bacteremia in pneumococcic pneumonia, Arch. Int. Med., 1937, lix, 602. CrossrefGoogle Scholar12. HODESSTIFLERWALKERMCCARTYSHIRLEY HLWCEMRG: The use of sulfapyridine in primary pneumococcic pneumonia and in pneumococcic pneumonia associated with measles, Jr. Pediat., 1939, xiv, 417. CrossrefGoogle Scholar13. DAVIES JA: The treatment of pneumococcal pneumonia in infants and children with sulfapyridine, New England Jr. Med., 1939, ccxxi, 734. CrossrefGoogle Scholar14. CAREY BW: The treatment of pneumonia in infants and children, Jr. Pediat., 1941, xviii, 153. CrossrefGoogle Scholar15. DOWLINGABERNETHY HFTJ: The causes of secondary fever in sulfapyridine-treated pneumonia, ANN. INT. MED., 1941, xiv, 1815. Google Scholar16. HAMBURGERRUEGSEGGER MJM: Early recurrence of sulfapyridine-treated type I pneumococcal pneumonia, New England Jr. Med., 1939, ccxxi, 445. CrossrefGoogle Scholar17. GREENE D: Recurrence of pneumonia in infancy and in early childhood, Am. Jr. Dis. Child., 1936, li, 284. CrossrefGoogle Scholar18. WARRALPERIN OSJ: Lobar pneumonia. A report of 2039 cases, ANN. INT. MED., 1933, vi, 1474. LinkGoogle Scholar19. LOWELLSTRAUSSFINLAND FCEM: Observations on the susceptibility of pneumococci to sulfapyridine, sulfathiazole, and sulfamethylthiazole, ANN. INT. MED., 1940, xiv, 1001. Google Scholar20. FINLANDSPRINGLOWELL MWCFC: Immunological studies on patients with pneumococcic pneumonia treated with sulfapyridine, Jr. Clin. Invest., 1940, xix, 179. CrossrefGoogle Scholar21. FINLANDSTRAUSSPETERSON MEOL: Antibody response of patients with pneumococcic pneumonia treated with sulfadiazine and sulfathiazole, ANN. INT. MED., 1942, xvi, 1-16. Google Scholar22. KNEELANDMULLIKEN YB: Antibody formation in cases of lobar pneumonia treated with sulfapyridine, Jr. Clin. Invest., 1940, xix, 307. CrossrefGoogle Scholar23. Idem: Antibody formation in cases of lobar pneumonia treated with sulfathiazole, Ibid., p. 735. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Boston, Massachusetts*Received for publication August 21, 1941.From the Thorndike Memorial Laboratory, Second and Fourth Medical Services (Harvard), Boston City Hospital and the Department of Medicine, Harvard Medical School, Boston. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byPneumococcal InfectionsPneumococcal InfectionsIsolation and characterization of circulating immune complexes from patients with pneumococcal pneumoniaPneumococcal antibody levels in patients with acute lung infiltratesPneumococcal Infections 1 January 1942Volume 16, Issue 1Page: 17-32KeywordsHospital medicineMedical servicesPneumococcusPneumoniaResearch laboratories Issue Published: 1 January 1942 PDF downloadLoading ...